Search Results - "Zorio, E"

Role of microRNAs in gynecological pathology by Gilabert-Estelles, J, Braza-Boils, A, Ramon, L A, Zorio, E, Medina, P, Espana, F, Estelles, A

“…microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and play fundamental roles in biological processes. These small molecules…”
Get more information

C0434: A Novel Tissue Microrna Signature for Arrhythmogenic Cardiomyopathy by Zorio, E, Plana, E, Fernández, E, Molina, P, Ángeles Andreu, M, Domingo, D, Sanz, J, Ángel Arnau, M, Salvador, A, España, F, Medina, P

Get full text

C0423: MicroRNAs in Sudden Cardiac Death from Coronary Artery Disease. Its Relationship with Dyslipidemia and Non-Alcoholic Fatty Liver Disease by Marí-Alexandre, J, Braza-Boils, A, Molina, P, Domingo, D, Abellán, Y, Sancho, J, Hevia, P, Ángel Arnau, M, Gómez, J, Giner, J, Salvador, A, Estellés, A, Zorio, E

Get full text

C0171: Identification of a MicroRNA Profile Related to Hypertrophic Cardiomyopathy by Plana, E, Domingo, D, Martos, L, Fernández, E, Sancho, J, Abellan, Y, del Carmen Salvador, M, Zorio, E, Ángel Arnau, M, Montero, A, España, F, Medina, P

Get full text

C0515: Identification of a Plasma Micrornas Profile Involved in Arterial Thrombosis by Navarro, S, Andres Ramon, L, Martos, L, Bonet, E, Dolores Sanchez-Izquierdo, M, Rueda, J, Angel Arnau, M, Zorio, E, Domingo, D, Medina, P, España, F

Get full text

C0420: MicroRNA Expression Profile in Epicardial Fat in Sudden Cardiac Death from Coronary Artery Disease by Braza-Boils, A, Marí-Alexandre, J, Molina, P, Domingo, D, Sanz, J, Sancho, J, Abellán, Y, Castillo, N, Ángel Arnau, M, Giner, J, Montero, A, Estellés, A, Zorio, E

Get full text

Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis by Gilabert‐Estellés, J., Estellés, A., Gilabert, J., Castelló, R., España, F., Falcó, C., Romeu, A., Chirivella, M., Zorio, E., Aznar, J.

“…BACKGROUND: Endometriosis is considered a benign disease that has the ability to invade normal tissue. As in neoplastic growth, local extracellular proteolysis…”
Get full text

Endothelial protein C receptor polymorphisms and risk of myocardial infarction by Medina, Pilar, Navarro, Silvia, Corral, Javier, Zorio, Esther, Roldan, Vanessa, Estelles, Amparo, Santamaria, Amparo, Marin, Francisco, Rueda, Joaquin, Bertina, Rogier M, Espana, Francisco, RECAVA Thrombosis Groups

“…1 Centro de Investigación, Hospital Universitario La Fe, Valencia, Spain 2 Centro Regional de Hemodonación, Universidad de Murcia, Murcia, Spain 3 Servicio de…”
Get full text

Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions by Zorio, E, Navarro, S, Medina, P, Estellés, A, Osa, A, Rueda, J, Cubillo, P, Aznar, J, España, F

“…Cardiovascular risk factors for myocardial infarction (MI) are less frequent in younger than in older MI survivors. Therefore, the thrombotic component of MI…”
Get full text

Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets by Zorio, E, Medina, P, Rueda, J, Millán, J M, Arnau, M A, Beneyto, M, Marín, F, Gimeno, J R, Osca, J, Salvador, A, España, F, Estellés, A

“…microRNAs have recently opened new pathways to explain gene expression and disease biology in many scenarios, including cardiac diseases. microRNAs are…”
Get more information

The −589C>T polymorphism in the interleukin‐4 gene (IL‐4) is associated with a reduced risk of myocardial infarction in young individuals by PAFFEN, E., MEDINA, P., DE VISSER, M. C. H., VAN WIJNGAARDEN, A., ZORIO, E., ESTELLÉS, A., ROSENDAAL, F. R., ESPAÑA, F., BERTINA, R. M., DOGGEN, C. J. M.

“…Background: Inflammatory reactions contribute to the development of arterial disease. We investigated the role of interleukin‐4 (IL‐4) in the development of…”
Get full text

Does Amiodarone Influence Early Mortality in Heart Transplantation? by Sánchez-Lázaro, I.J., Almenar, L., Martinez-Dolz, L., Chamorro, C., Moro, J., Agüero, J., Rueda, J., Zorio, E., Arnau, M.A., Salvador, A.

“…The use of amiodarone before transplantation has been linked to an increased number of complications, acute graft failures, and early mortality after a heart…”
Get full text

Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease by CID, A. R., ZORIO, E., HAYA, S., ZÚÑIGA, P., RUEDA, J., CASAÑA, P., CABRERA, N., ARNAU, M. A., AZNAR, J. A.

Get full text

Influence of Immunosuppression Regimen on Heart Transplantation Survival by Agüero, J., Almenar, L., Martı́nez-Dolz, L., Chamorro, C., Moro, J., Rueda, J., Arnau, M.A., Zorio, E., Izquierdo, M., Salvador, A.

“…To perform an analysis comparing long-term survival in heart transplant (HT) patients depending on the immunosuppressive regimen. The study included 317…”
Get full text

Induction Therapy With Daclizumab in Heart Transplantation—How Many Doses? by Ortiz, V., Almenar, L., Martínez-Dolz, L., Zorio, E., Chamorro, C., Moro, J., Agüero, J., Rueda, J., Arnau, M.A., Salvador, A.

“…Since their introduction onto the market, interleukin-2 antagonists have been increasingly used by a growing number of transplant units. Their benefits versus…”
Get full text

Variations in the Frequency and Type of Infections in Heart Transplantation According to the Immunosuppression Regimen by Agüero, J., Almenar, L., Martinez-Dolz, L., Chamorro, C., Moro, J., Zorio, E., Arnau, M.Á., Rueda, J., Izquierdo, M., Salvador, A.

“…To evaluate the frequency of infection according to the immunosuppressive regimens used in our center. From 259 consecutive heart transplants we excluded…”
Get full text

Is There a Correlation Between Brain Naturietic Peptide Levels and Echocardiographic and Hemodynamic Parameters in Heart Transplant Patients? by Almenar, L., Arnau, M.A., Martı́nez-Dolz, L., Hervás, I., Osa, A., Miró, V., Sánchez, E., Zorio, E., Rueda, J., Mateo, A., Salvador, A.

“…Brain naturietic peptide (BNP) elevations have been reported in heart transplant patients both at baseline and during rejection. An association between BNP…”
Get full text

Evolutional Changes in Maintenance Immunosuppression Following Heart Transplantation by Sánchez-Lázaro, I., Almenar, L., Martínez-Dolz, L., Chamorro, C., Moro, J., Agüero, J., Rueda, J., Zorio, E., Arnau, M.A., Salvador, A.

“…Patients with a heart transplant (HT) may require changes in their immunosuppressive maintenance medication. The basic treatment regimen in our patients…”
Get full text

Risk Factors Affecting Survival in Heart Transplant Patients by Almenar, L., Cardo, M.L., Martı́nez-Dolz, L., Garcı́a-Palomar, C., Rueda, J., Zorio, E., Arnau, M.Á., Osa, A., Palencia, M.

“…Certain cardiovascular risk factors have been linked to morbidity and mortality in heart transplant (HT) patients. The sum of various risk factors may have a…”
Get full text

Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator by Protonotarios, Alexandros, Bariani, Riccardo, Cappelletto, Chiara, Pavlou, Menelaos, García-García, Alba, Cipriani, Alberto, Protonotarios, Ioannis, Rivas, Adrian, Wittenberg, Regitze, Graziosi, Maddalena, Xylouri, Zafeirenia, Larrañaga-Moreira, José M, de Luca, Antonio, Celeghin, Rudy, Pilichou, Kalliopi, Bakalakos, Athanasios, Lopes, Luis Rocha, Savvatis, Konstantinos, Stolfo, Davide, Dal Ferro, Matteo, Merlo, Marco, Basso, Cristina, Freire, Javier Limeres, Rodriguez-Palomares, Jose F, Kubo, Toru, Ripoll-Vera, Tomas, Barriales-Villa, Roberto, Antoniades, Loizos, Mogensen, Jens, Garcia-Pavia, Pablo, Wahbi, Karim, Biagini, Elena, Anastasakis, Aris, Tsatsopoulou, Adalena, Zorio, Esther, Gimeno, Juan R, Garcia-Pinilla, Jose Manuel, Syrris, Petros, Sinagra, Gianfranco, Bauce, Barbara, Elliott, Perry M

“…To study the impact of genotype on the performance of the 2019 risk model for arrhythmogenic right ventricular cardiomyopathy (ARVC). The study cohort…”
Get full text